GEUSENS, Piet

Email Alert RSS Feed

Profile

Full Name
GEUSENS, Piet
Email
piet.geusens@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 261-280 of 447 (Search time: 0.007 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
2612005Efficacy and Safety of Infliximab in Patients With Ankylosing SpondylitisVAN DER HEIJDE, Desiree; Dijkmans, B.; GEUSENS, Piet; Sieper, J.; DeWoody, K.; Williamson, P.; Braun, J.Journal ContributionA1
2622005Improvement in-clinical measures of psoriatic arthritis in infliximab-treated patients: 1 year results from IMPACT 2.Kavanaugh, A; Antoni, C.E.; Krueger, GG; Gladman, D; Birbara, C; Boling, EP; Siegel, EL; Halter, DG; de Vlam, K; Kirkham, B; Beutler, A; Guzzo, C; Zhou, B; Dooley, LT; Mease, Philip J.; GEUSENS, PietJournal ContributionM
2632005Infliximab therapy results in sustained improvement in functional status and quality of life in patients with psoriatic arthritis - Results from the IMPACT 2 study.Kavanaugh, A; Antoni, C.E.; Krueger, GG; GEUSENS, Piet; e Vlam, K; Birbara, C; Beutler, A; Zhou, B; Dooley, LT; Guzzo, C; Wu, Y; Bala, M.; Gladman, DJournal ContributionM
2642005Treatment with infliximab is associated with "Major clinical response" in psoriatic arthritis patients treated with infliximab: Analysis of two double-blind placebo controlled trials.Kavanaugh, A; Krueger, GG; Birbara, C; Halter, D; de Vlam, K; Zhou, B; Dooley, L; Guzzo, C; Bala, M.; Beutler, A; Antoni, C.; GEUSENS, PietJournal ContributionM
2652005Newer drug treatments: Their effects on fracture preventionGEUSENS, Piet; Reid, DJournal ContributionA1
2662005Osteoporosis and fall risk in patients with fragility fracturesvan Helden, SH; Nieuwenhuijzen-Kruseman, AC; Dinant, G; Pijpers, E; ten Broeke, R; Brink, PR; GEUSENS, PietJournal ContributionM
2672005VDR gene polymorphism and falls in the elderly.Bischoff-Ferrari, HA; Conzelman, M; Staehelin, HB; Theiler, R; Dick, W; GEUSENS, PietJournal ContributionM
2682005A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoidsvan Staa, TP; GEUSENS, Piet; Pols, HAP; de Laet, C; Leufkens, HGM; Cooper, CJournal ContributionA1
2692005Cost-effectiveness analysis of Aclasta in Paget's disease of bone in BelgiumLecomte, P; Devogelaer, JP; Kaufman, JM; Goemaere, S; Engbersen, A; GEUSENS, PietJournal ContributionM
2702005Characteristics and performance of an immunosorbent assay for human matrix Gla-proteinSCHURGERS, Jo; Teunissen, KJF; Knapen, MHJ; GEUSENS, Piet; VAN DER HEIJDE, Desiree; Kwaijtaal, M; van Diest, R; Ketteler, M; Vermeer, CJournal ContributionA1
2712005Differences in exposure to stimulatory and inhibitory components of the insulin-like growth factor (IGF) system in patients with femoral neck versus trochanteric fractureBoonen, S; Vanderschueren, D; VENKEN, Koen; GEUSENS, Piet; Haentjens, P; Mohan, S; Baylink, D.J.; Bouillon, RJournal ContributionA1
2722005Synovial fluid NKT cells display different properties compared to peripheral blood NKT cells in rheumatoid arthritisLINSEN, Loes; SOMERS, Veerle; THEWISSEN, Marielle; GEUSENS, Piet; RAUS, Jef; STINISSEN, PietJournal ContributionM
2732005Peripheral blood but not synovial fluid natural killer T cells are biased towards a Th1-like phenotype in rheumatoid arthritisLINSEN, Loes; THEWISSEN, Marielle; BAETEN, Kurt; SOMERS, Veerle; GEUSENS, Piet; RAUS, Jef; STINISSEN, PietJournal ContributionA1
2742005Synovial fluid NKT cells display different properties compared to peripheral blood NKT cells in rheumatoid arthritisLINSEN, Loes; SOMERS, Veerle; THEWISSEN, Marielle; GEUSENS, Piet; RAUS, Jef; STINISSEN, PietJournal ContributionM
2752005Premature senescence of the immune system in rheumatoid arthritis and multiple sclerosis patients.LINSEN, Loes; THEWISSEN, Marielle; GEUSENS, Piet; RAUS, Jef; STINISSEN, PietJournal ContributionM
2762005Premature Immunosenescence in Rheumatoid Arthritis and Multiple Sclerosis PatientsTHEWISSEN, Marielle; LINSEN, Loes; SOMERS, Veerle; GEUSENS, Piet; RAUS, Jef; STINISSEN, PietJournal ContributionA1
2772005Hip bone mineral density, bone turnover and risk of fracture in patients on long-term suppressive L-thyroxine therapy for differentiated thyroid carcinomaHeijckmann, A.C.; Huijberts, M.S.P.; GEUSENS, Piet; de Vries, J.; Menheere, Paul P. C. A.; Wolffenbuttel, B.H.R.Journal ContributionA1
2782005Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fracturesHochberg, M.C.; Thompson, D.E.; Black, D.M.; Quandt, S.A.; Cauley, J.; GEUSENS, Piet; Ross, P.D.; Baran, D.Journal ContributionA1
2792005Femoral Neck Trabecular Microstructure in Ovariectomized Ewes Treated With Calcitonin: MRI Microscopic EvaluationJiang, Y.; Zhao, J.; GEUSENS, Piet; Liao, E-Y.; ADRIAENSENS, Peter; GELAN, Jan; Azria, M.; Boonen, S.; Caulin, F.; Lynch, J.A.; Ouyang, X.; Genant, H.K.Journal ContributionA1
2802005Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: Reduction in risk of nonvertebral fracture is not related to change in BMDWatts, N.B.; GEUSENS, Piet; Barton, I.; Felsenberg, D.Journal ContributionA1
show all